FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069461319> ?p ?o ?g. }

• W2069461319 endingPage "811" @default.
• W2069461319 startingPage "805" @default.
• W2069461319 abstract "(90)Y has been used to label various new therapeutic radiopharmaceuticals. However, measuring the radiation dose delivered by (90)Y is challenging because of the absence of suitable γ emissions and its low abundance of positron emissions. For the treatment of prostate cancer, radiolabeled gastrin-releasing peptide receptor (GRPr) antagonists have yielded promising results in mouse models. In this study, we evaluated whether Cerenkov luminescence imaging (CLI) could be used to determine radiation doses of a (90)Y-labeled GRPr antagonist in nude mice.Mice bearing subcutaneous prostate cancer xenografts were injected with 0.74-18.5 MBq of the (90)Y-labeled GRPr antagonist DOTA-AR and underwent in vivo and ex vivo CLI at 1-48 h after injection. After imaging, animals were sacrificed, their tumors and organs were harvested, and the activity concentration was measured by liquid scintillation counting. In a second set of experiments, Cerenkov photon counts for tumor and kidney on in vivo CLI were converted to activity concentrations using conversion factors determined from the first set of experiments.(90)Y-DOTA-AR concentration in the 3 tumor models ranged from 0.5% to 4.8% of the injected activity per gram at 1 h after injection and decreased to 0.05%-0.15 injected activity per gram by 48 h after injection. A positive correlation was found between tumor activity concentrations and in vivo CLI signal (r(2) = 0.94). A similar correlation was found for the renal activity concentration and in vivo Cerenkov luminescence (r(2) = 0.98). Other organs were not distinctly visualized on the in vivo images, but ex vivo CLI was also correlated with the radioactivity concentration (r(2) = 0.35-0.94). Using the time-activity curves from the second experiment, we calculated radiation doses to tumor and kidney of 0.33 ± 0.12 (range, 0.21-0.66) and 0.06 ± 0.01 (range, 0.05-0.08) Gy/MBq, respectively.CLI is a promising, low-cost modality to measure individual radiation doses of (90)Y-labeled compounds noninvasively. The use of Cerenkov imaging is expected to facilitate the development and comparison of (90)Y-labeled compounds for targeted radiotherapy." @default.
• W2069461319 created "2016-06-24" @default.
• W2069461319 creator A5015901356 @default.
• W2069461319 creator A5039475847 @default.
• W2069461319 creator A5042102358 @default.
• W2069461319 creator A5052210865 @default.
• W2069461319 creator A5056859109 @default.
• W2069461319 creator A5067808348 @default.
• W2069461319 creator A5069617434 @default.
• W2069461319 creator A5075098977 @default.
• W2069461319 creator A5080877411 @default.
• W2069461319 creator A5088776966 @default.
• W2069461319 date "2015-04-03" @default.
• W2069461319 modified "2023-09-27" @default.
• W2069461319 title "Cerenkov Luminescence Imaging for Radiation Dose Calculation of a ⁹⁰Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist" @default.
• W2069461319 cites W1963799411 @default.
• W2069461319 cites W1975602223 @default.
• W2069461319 cites W1980913229 @default.
• W2069461319 cites W1996715706 @default.
• W2069461319 cites W2001071537 @default.
• W2069461319 cites W2005674134 @default.
• W2069461319 cites W2015712231 @default.
• W2069461319 cites W2020567724 @default.
• W2069461319 cites W2046842891 @default.
• W2069461319 cites W2049763190 @default.
• W2069461319 cites W2062197775 @default.
• W2069461319 cites W2070460029 @default.
• W2069461319 cites W2080742973 @default.
• W2069461319 cites W2081710978 @default.
• W2069461319 cites W2086439980 @default.
• W2069461319 cites W2092420790 @default.
• W2069461319 cites W2094897052 @default.
• W2069461319 cites W2097537182 @default.
• W2069461319 cites W2106618401 @default.
• W2069461319 cites W2109669845 @default.
• W2069461319 cites W2112799946 @default.
• W2069461319 cites W2115690563 @default.
• W2069461319 cites W2128349096 @default.
• W2069461319 cites W2135099770 @default.
• W2069461319 cites W2142421794 @default.
• W2069461319 cites W2144862049 @default.
• W2069461319 cites W2150176078 @default.
• W2069461319 cites W2155585459 @default.
• W2069461319 cites W2159219486 @default.
• W2069461319 cites W2164273655 @default.
• W2069461319 cites W2169382529 @default.
• W2069461319 cites W2169961966 @default.
• W2069461319 cites W2219978888 @default.
• W2069461319 cites W4255451295 @default.
• W2069461319 cites W64452830 @default.
• W2069461319 doi "https://doi.org/10.2967/jnumed.114.149054" @default.
• W2069461319 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4470706" @default.
• W2069461319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25840974" @default.
• W2069461319 hasPublicationYear "2015" @default.
• W2069461319 type Work @default.
• W2069461319 sameAs 2069461319 @default.
• W2069461319 citedByCount "37" @default.
• W2069461319 countsByYear W20694613192015 @default.
• W2069461319 countsByYear W20694613192016 @default.
• W2069461319 countsByYear W20694613192017 @default.
• W2069461319 countsByYear W20694613192018 @default.
• W2069461319 countsByYear W20694613192019 @default.
• W2069461319 countsByYear W20694613192020 @default.
• W2069461319 countsByYear W20694613192021 @default.
• W2069461319 countsByYear W20694613192022 @default.
• W2069461319 countsByYear W20694613192023 @default.
• W2069461319 crossrefType "journal-article" @default.
• W2069461319 hasAuthorship W2069461319A5015901356 @default.
• W2069461319 hasAuthorship W2069461319A5039475847 @default.
• W2069461319 hasAuthorship W2069461319A5042102358 @default.
• W2069461319 hasAuthorship W2069461319A5052210865 @default.
• W2069461319 hasAuthorship W2069461319A5056859109 @default.
• W2069461319 hasAuthorship W2069461319A5067808348 @default.
• W2069461319 hasAuthorship W2069461319A5069617434 @default.
• W2069461319 hasAuthorship W2069461319A5075098977 @default.
• W2069461319 hasAuthorship W2069461319A5080877411 @default.
• W2069461319 hasAuthorship W2069461319A5088776966 @default.
• W2069461319 hasBestOaLocation W20694613191 @default.
• W2069461319 hasConcept C150903083 @default.
• W2069461319 hasConcept C170493617 @default.
• W2069461319 hasConcept C177322064 @default.
• W2069461319 hasConcept C185592680 @default.
• W2069461319 hasConcept C202751555 @default.
• W2069461319 hasConcept C207001950 @default.
• W2069461319 hasConcept C26291073 @default.
• W2069461319 hasConcept C2776885963 @default.
• W2069461319 hasConcept C2989005 @default.
• W2069461319 hasConcept C55493867 @default.
• W2069461319 hasConcept C71924100 @default.
• W2069461319 hasConcept C86803240 @default.
• W2069461319 hasConceptScore W2069461319C150903083 @default.
• W2069461319 hasConceptScore W2069461319C170493617 @default.
• W2069461319 hasConceptScore W2069461319C177322064 @default.
• W2069461319 hasConceptScore W2069461319C185592680 @default.
• W2069461319 hasConceptScore W2069461319C202751555 @default.
• W2069461319 hasConceptScore W2069461319C207001950 @default.
• W2069461319 hasConceptScore W2069461319C26291073 @default.
• W2069461319 hasConceptScore W2069461319C2776885963 @default.

• next